A 69-yr-old man with bilateral and metastatic renal cell carcinoma developed progressive disease after interleukin-2 and interferon therapy. He was submitted to radical left nephrectomy, right nephron-sparing surgery, and bone metastasis removal, followed by therapy with sorafenib. At 12-mo follow-up there was a significant improvement in patient performance status and no evidence of clinical progression.
Adjuvant therapy with sorafenib in bone metastases bilateral renal carcinoma: a case report / Sciarra, Alessandro; Ana Maria Autran, Gomez; Gentilucci, Alessandro; Salciccia, Stefano; Parente, Ulderico; Vincenzo, Gentile; DI SILVERIO, Franco. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - 52:2(2007), pp. 597-599. [10.1016/j.eururo.2007.03.083]
Adjuvant therapy with sorafenib in bone metastases bilateral renal carcinoma: a case report.
SCIARRA, Alessandro;GENTILUCCI, ALESSANDRO;SALCICCIA, STEFANO;PARENTE, ULDERICO;DI SILVERIO, Franco
2007
Abstract
A 69-yr-old man with bilateral and metastatic renal cell carcinoma developed progressive disease after interleukin-2 and interferon therapy. He was submitted to radical left nephrectomy, right nephron-sparing surgery, and bone metastasis removal, followed by therapy with sorafenib. At 12-mo follow-up there was a significant improvement in patient performance status and no evidence of clinical progression.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
